Cargando…
Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancer
Metastatic prostate cancer is one of the leading causes of cancer-related death in men. The primary site of metastasis from prostate cancers is the bone. During the last decade, multiple studies have pointed to the role of the stromal cell-derived factor 1 alpha (SDF1α)/CXCR4 axis in the metastatic...
Autores principales: | Gupta, Nisha, Duda, Dan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885164/ https://www.ncbi.nlm.nih.gov/pubmed/27533927 http://dx.doi.org/10.7555/JBR.30.20150114 |
Ejemplares similares
-
Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α
por: Mognetti, Barbara, et al.
Publicado: (2013) -
Controlled Release of Encapsuled Stromal-Derived Factor 1α Improves Bone Marrow Mesenchymal Stromal Cells Migration
por: Bajdak-Rusinek, Karolina, et al.
Publicado: (2022) -
Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
por: Johnson, Catherine S., et al.
Publicado: (2023) -
Bone morphogenetic protein pathway responses and alterations of osteogenesis in metastatic prostate cancers
por: Provera, Meredith D., et al.
Publicado: (2022) -
Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models
por: Gupta, Nisha, et al.
Publicado: (2023)